How omnichannel strategies improved GLP-1 medication adherence

Patient adherence to GLP-1 medications remains a challenge for pharmaceutical manufacturers, with high void rates and non-adherence causing revenue losses and poor health outcomes.

This case study shows how a Fortune 500 life sciences manufacturer addressed these issues by adopting an AI-powered omnichannel strategy. Results include improved targeting and adherence:

· Predictive analytics identified patients likely to adhere
· Multi-channel communication via SMS, direct mail, and in-store interactions boosted engagement
· Data-driven targeting achieved 5.9:1 ROI and $7.4M in revenue

Learn how omnichannel strategies improve adherence outcomes.